Literature DB >> 9099746

Identification of a region within the ubiquitin-activating enzyme required for nuclear targeting and phosphorylation.

A G Stephen1, J S Trausch-Azar, P M Handley-Gearhart, A Ciechanover, A L Schwartz.   

Abstract

The ubiquitin-activating enzyme exists as two isoforms: E1a, localized predominantly in the nucleus, and E1b, localized in the cytoplasm. Previously we generated hemagglutinin (HA) epitope-tagged cDNA constructs, HA1-E1 (epitope tag placed after the first methionine) and HA2-E1 (epitope tag placed after the second methionine) (Handley-Gearhart, P. M., Stephen, A. G., Trausch-Azar, J. S., Ciechanover, A., and Schwartz, A. L. (1994) J. Biol. Chem. 269, 33171-33178), which represent the native isoforms. HA1-E1 is exclusively nuclear, whereas HA2-E1 is found predominantly in the cytoplasm. Using high resolution isoelectric focusing and SDS-polyacrylamide gel electrophoresis, we confirm that these epitope-tagged constructs HA1-E1 and HA2-E1 represent the two isoforms E1a and E1b. HA1-E1/E1a exists as one non-phosphorylated and four phosphorylated forms, and HA2-E1/E1b exists as one predominant non-phosphorylated form and two minor phosphorylated forms. We demonstrate that the first 11 amino acids are essential for phosphorylation and exclusive nuclear localization of HA1-E1. Within this region are four serine residues and a putative nuclear localization sequence (NLS; 5PLSKKRR). Removal of these four serine residues reduced phosphorylation levels by 60% but had no effect on nuclear localization of HA1-E1. Each serine residue was independently mutated to an alanine and analyzed by two-dimensional electrophoresis; only serine 4 was phosphorylated. Disruption of the basic amino acids within the NLS resulted in loss of exclusive nuclear localization and a 90-95% decrease in the phosphorylation of HA1-E1. This putative NLS was able to confer nuclear import on a non-nuclear protein in digitonin-permeabilized cells in a temperature- and ATP-dependent manner. Thus the predominant requirement for efficient phosphorylation of HA1-E1/E1a is a functional NLS, suggesting that E1a may be phosphorylated within the nucleus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099746     DOI: 10.1074/jbc.272.16.10895

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Impaired nucleotide excision repair upon macrophage differentiation is corrected by E1 ubiquitin-activating enzyme.

Authors:  Thierry Nouspikel; Philip C Hanawalt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

Review 2.  Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.

Authors:  Keith A Sikora; Kristina V Wells; Ertugrul Cagri Bolek; Adrianna I Jones; Peter C Grayson
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

3.  Dynamics of re-constitution of the human nuclear proteome after cell division is regulated by NLS-adjacent phosphorylation.

Authors:  Gergely Róna; Máté Borsos; Jonathan J Ellis; Ahmed M Mehdi; Mary Christie; Zsuzsanna Környei; Máté Neubrandt; Judit Tóth; Zoltán Bozóky; László Buday; Emília Madarász; Mikael Bodén; Bostjan Kobe; Beáta G Vértessy
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Expression, purification and characterization of human ubiquitin-activating enzyme, UBE1.

Authors:  Mei Zheng; Jing Liu; Zhenxing Yang; Xing Gu; Fan Li; Tiantian Lou; Chaoneng Ji; Yumin Mao
Journal:  Mol Biol Rep       Date:  2009-04-03       Impact factor: 2.316

5.  A novel strategy to isolate ubiquitin conjugates reveals wide role for ubiquitination during neural development.

Authors:  Maribel Franco; Nicholas T Seyfried; Andrea H Brand; Junmin Peng; Ugo Mayor
Journal:  Mol Cell Proteomics       Date:  2010-09-22       Impact factor: 5.911

Review 6.  UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration.

Authors:  Ewout J N Groen; Thomas H Gillingwater
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

7.  SAK-HV Decreases the Self-Ubiquitination of MEKK1 to Promote Macrophage Proliferation via MAPK/ERK and JNK Pathways.

Authors:  Chao Zhang; Yao Chen; Xiangdong Gan; Zhiguang Huang; Minji Zou; Wenliang Fu; Weiwei Xing; Donggang Xu
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

8.  Characterization of ubiquitin-activating enzyme Uba1 in the nucleus by its mammalian temperature-sensitive mutant.

Authors:  Kimihiko Sugaya; Yoshie Ishihara; Sonoe Inoue; Hideo Tsuji
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

9.  Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy.

Authors:  Rachael A Powis; Evangelia Karyka; Penelope Boyd; Julien Côme; Ross A Jones; Yinan Zheng; Eva Szunyogova; Ewout Jn Groen; Gillian Hunter; Derek Thomson; Thomas M Wishart; Catherina G Becker; Simon H Parson; Cécile Martinat; Mimoun Azzouz; Thomas H Gillingwater
Journal:  JCI Insight       Date:  2016-07-21

10.  Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.

Authors:  David B Beck; Marcela A Ferrada; Keith A Sikora; Amanda K Ombrello; Jason C Collins; Wuhong Pei; Nicholas Balanda; Daron L Ross; Daniela Ospina Cardona; Zhijie Wu; Bhavisha Patel; Kalpana Manthiram; Emma M Groarke; Fernanda Gutierrez-Rodrigues; Patrycja Hoffmann; Sofia Rosenzweig; Shuichiro Nakabo; Laura W Dillon; Christopher S Hourigan; Wanxia L Tsai; Sarthak Gupta; Carmelo Carmona-Rivera; Anthony J Asmar; Lisha Xu; Hirotsugu Oda; Wendy Goodspeed; Karyl S Barron; Michele Nehrebecky; Anne Jones; Ryan S Laird; Natalie Deuitch; Dorota Rowczenio; Emily Rominger; Kristina V Wells; Chyi-Chia R Lee; Weixin Wang; Megan Trick; James Mullikin; Gustaf Wigerblad; Stephen Brooks; Stefania Dell'Orso; Zuoming Deng; Jae J Chae; Alina Dulau-Florea; May C V Malicdan; Danica Novacic; Robert A Colbert; Mariana J Kaplan; Massimo Gadina; Sinisa Savic; Helen J Lachmann; Mones Abu-Asab; Benjamin D Solomon; Kyle Retterer; William A Gahl; Shawn M Burgess; Ivona Aksentijevich; Neal S Young; Katherine R Calvo; Achim Werner; Daniel L Kastner; Peter C Grayson
Journal:  N Engl J Med       Date:  2020-10-27       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.